Logo
x

Search

Subscribe Now

MPS IIIA

Abeona Signs Exclusive License Agreement with Regenxbio to Develop and Commercialize NAV AAV9 vector

Abeona Signs Exclusive License Agreement with Regenxbio to Develop and Commercialize NAV AAV9 vector

  • November 6, 2018
Sarepta Signs an Exclusive Global (Except EU) License Agreement with Lysogene for LYS-SAF302 to Treat MPS IIIA

Sarepta Signs an Exclusive Global (Except EU) License Agreement with Lysogene for LYS-SAF302 to Treat MPS IIIA

  • October 16, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.